These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 32649404)
1. The Role of Tocilizumab in the Treatment of Adult-Onset Still Disease-Report of a Tertiary Single-Center Experience. Almeida DE; Costa E; Neves JS; Cerqueira M; Ribeiro AR J Clin Rheumatol; 2021 Dec; 27(8S):S875-S876. PubMed ID: 32649404 [No Abstract] [Full Text] [Related]
4. Long-term safety of tocilizumab treatment on chronic active hepatitis C in a patient with adult onset Still's disease. Forestier E; Pasquali JL Joint Bone Spine; 2015 Mar; 82(2):136-7. PubMed ID: 25553837 [No Abstract] [Full Text] [Related]
5. Efficacy of tocilizumab in refractory adult-onset Still's disease; report of 2 cases. Andrade-Ortega L; Irazoque-Palazuelos F; Muñoz-López S; Rosales-Don Pablo VM Reumatol Clin; 2014; 10(3):199-200. PubMed ID: 24076178 [No Abstract] [Full Text] [Related]
6. Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial. Kaneko Y; Kameda H; Ikeda K; Ishii T; Murakami K; Takamatsu H; Tanaka Y; Abe T; Takeuchi T Ann Rheum Dis; 2018 Dec; 77(12):1720-1729. PubMed ID: 30279267 [TBL] [Abstract][Full Text] [Related]
8. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab. Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930 [TBL] [Abstract][Full Text] [Related]
9. Tocilizumab for the treatment of adult-onset Still's disease. Castañeda S; Martínez-Quintanilla D; Martín-Varillas JL; García-Castañeda N; Atienza-Mateo B; González-Gay MA Expert Opin Biol Ther; 2019 Apr; 19(4):273-286. PubMed ID: 30827128 [TBL] [Abstract][Full Text] [Related]
10. Biomarkers for disease flare in patients with adult-onset Still's disease undergoing treatment with tocilizumab. Yamada H; Kaneko Y; Tamai H; Takeuchi T Rheumatology (Oxford); 2020 Feb; 59(2):440-442. PubMed ID: 31504968 [No Abstract] [Full Text] [Related]